Similar Articles
Middle Latency Somatosensory Evoked Potentials in Hemiparkinsonism
A. SOYSAL, F. ÖZER, B. ARPACI
lron Deficiency and Restless Legs Syndrome; Three Cases
C. TOGAY IŞIKAY, A. BİNGÖL, N. MUTLUER
Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease
Ayhan ÖZTÜRK, Hilmi UYSAL
Subacute Myleo-Optic Neuropathy- Case Report
Egemen VARDARLI, Gürbüz GÜMÜŞDİŞ, Sevgi TAVUS
New Developments in Parkinson's Disease Management
M. Cenk AKBOSTANCI
P300 and P300 Topographic Mapping in Parkinson's Disease
Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU
Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.
Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
Epigenetic analysis of heat shock activator complex in the peripheral blood of Parkinson's disease patients and its clinical significance
Yagmur İnalkac Gemici, Irem Tasci, Muhammed Dundar, Nazmi Ozgen, Nefsun Danis, Harika Gozde Gozukara, Ahmet Koc
DOI: 10.55697/tnd.2024.110
Impact of a 12-week structured exercise program on motor function and exosomal alpha-synuclein levels in Parkinson's disease: A prospective analysis
Nihat Mustafayev, Abdulkadir Tunç, Birsen Elibol, Kamer Unal Eren, Sule Terzioglu-Usak
DOI: 10.55697/tnd.2024.8
Impulse control disorders related cognitive and behavioral features in Parkinson’s disease
Esra Erkoc Ataoglu, Yasemin Bozdağ, Ayse Bora Tokcaer
DOI: 10.55697/tnd.2024.109
Scale consistance in cognitive status awareness of patients with Parkinson’s disease
Sabiha Tezcan Aydemir, Elif Yüsra Unutmaz, Pınar Özkan, Talha Abalı, Gülnur Ayık, Dudu Genç Batmaz, Sema Nur Kibrit, Ahmet Veli Karacan, Müge Kuzu Kumcu, Merve Koç Yekedüz, Fatma Tuba Eminoğlu, Rezzak Yılmaz, Muhittin Cenk Akbostancı
DOI: 10.55697/tnd.2024.139
The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment
Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil
DOI: 10.55697/tnd.2025.216
Relationship between subjective sleep quality and serum ghrelin levels in Parkinson’s disease
Alper Ayaslı, Yıldız Değirmenci, Davran Fat, Mehmet Ali Sungur
DOI: 10.55697/tnd.2025.137
Efficacy and safety of intravenous thrombolytic therapy in acute ischemic stroke: Predictors of good prognosis and outcomes of the elderly population
Burak Gürel, Vedat Ali Yürekli
DOI: 10.55697/tnd.2026.578